Literature DB >> 24410724

Patient characteristics, histopathological findings and outcome in 97 cats with extranodal subcutaneous lymphoma (2007-2011).

K Meichner1, W von Bomhard2.   

Abstract

This study describes epidemiologic, clinical, macro- and microscopic tumour characteristics and outcome in 97 cats with subcutaneous lymphoma, an uncommon variant of feline extranodal lymphoma. Middle-aged (median 11 years), male (60.8%), Domestic Shorthair cats (89.7%) were commonly affected. Most tumours presented as a painless, firm, subcutaneous nodule or mass, with predilection to the lateral thoracic or abdominal wall, and the interscapular region. Deep subcutaneous invasion with extension into superficial or underlying tissues, extensive central areas of necrosis and peripheral inflammation were characteristic histopathological findings. Prevalence of retroviral infection was low. Local relapses after therapy were common (43.5%), and 32.2% had distant involvement later in course. Median overall survival was 148 days. Subcutaneous lymphoma should be considered a rare but important differential diagnosis for a subcutaneous mass in cats. Tumours show an aggressive biological behaviour. Treatment options including prognosis should be investigated in further studies.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  feline; histopathology; lymphosarcoma; skin

Mesh:

Year:  2014        PMID: 24410724     DOI: 10.1111/vco.12081

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  2 in total

1.  Primary angiocentric/angioinvasive T-cell lymphoma of the tympanic bulla in a feline leukaemia virus-positive cat.

Authors:  Sara F Santagostino; Carlo M Mortellaro; Julia Buchholz; Margherita Lugli; Annalisa Forlani; Gabriele Ghisleni; Paola Roccabianca
Journal:  JFMS Open Rep       Date:  2015-07-06

2.  Multifocal cutaneous non-epitheliotropic B-cell lymphoma in a cat.

Authors:  Fausto Quintavalla; Rosanna Di Lecce; Daniele Carlini; Matteo Zanfabro; Anna M Cantoni
Journal:  JFMS Open Rep       Date:  2020-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.